Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
Observations of spontaneous cherubism based on two cases and a literature review
 
More details
Hide details
1
Department of Maxillofacial Surgery, University Clinical Hospital, Rzeszow, Poland
 
2
Institute of Medical Sciences, the University of Rzeszow, Rzeszow, Poland
 
3
Institute of Health Science, the University of Rzeszow, Rzeszow, Poland
 
 
Submission date: 2023-01-10
 
 
Final revision date: 2023-08-22
 
 
Acceptance date: 2023-08-23
 
 
Publication date: 2023-12-30
 
 
Corresponding author
Michał Bałuszyński
Michał Bałuszyński Department of Maxillofacial Surgery University Clinical Hospital Rzeszow, Poland
 
 
Medical Studies 2023;39(4):389-395
 
KEYWORDS
TOPICS
ABSTRACT
Cherubism is a genetically determined illness characterized by osseus lesions of the facial part of the skull. X-ray and histopathological analysis of cherubism show it to be similar to fibrosis dysplasia, a brown tumour that occurs in the parathyroids or giant cells. Our paper describes 2 cases of cherubism. In each of them, X-ray examination, histopathological analysis and genetic tests led to a diagnosis. In this study, in the first case, there was no mutation in the SH3BP2 gene, which does not exclude the possibility that the mutation occurs in another gene. In the second case, in a patient diagnosed with cherubism after many years of observation and when clinical symptoms had worsened, genetic tests confirmed a mutation in exon 9 of the SH3BP2 gene.
REFERENCES (25)
1.
Barnes L, Evenson JW, Reichart P. WHO Clasification of tumours. Pathology and Genetics Head and Neck Tumours. IARC. Press Lyon 2005.
 
2.
Karczmarzyk T, Stypułkowska J, Tomaszewska R, Czopek J. Nowotwory zębopochodne i guzy nowotworopodobne kości szczękowych. Wydawnictwo Kwintesencja 2009; 107-116.
 
3.
Jones WA. Familial multilocular cystis disease of the jaw. Am J Cancer 1933; 17: 946-950.
 
4.
Syryńska M, Szyszka L, Post M. Rodzinna dysplazja włóknista jako jeden z objawów zespołu chorobowego czy tylko cherubizm. Rocznik PAM, Szczecin 2010; 56: 74-80.
 
5.
White S, Pharoah M. Radiologia stomatologiczna. Wydawnictwo Czelej, Wrocław 2002.
 
6.
Anderson DE, Mc Cledon JL. Cherubism – hereditary fibrous dysplasia of the jaws. Oral Surg Oral Med Pathol 1962; 15: 5-15.
 
7.
Fonesca LC, Freitas JB, Maciel PH, Calvalcanti MG. Temporal bone involvment in cherubism: case report. Braz Dental J 2004; 15: 75-78.
 
8.
Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, Ninomiya C, doAmaral C, Peters H, Habal M, Rhee-Morris L, Doss JB, Kreiborg S, Olsen BR, Reichenberger E. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat genet 2001; 28: 125-126.
 
9.
Kozakiewicz M, Perczyńska-Partyk W, Kobos J. Cherubism clinical picture and treatment. Oral Dis 2001; 7: 123-130.
 
10.
Von Wowern N. Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 765-772.
 
11.
Lietman SA, Yin L, Levine MA. SH3BP2 is an activator of NFAT activity and osteoclastogenesis. Biochem Biophys Res Commun 2008; 371: 644-648.
 
12.
Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat 2006; 27: 717-718.
 
13.
Wang CJ, Chen IP, Koczon-Jaremko B, Boskey AL, Ueki Y, Khun L, Reichenberger EJ. Pro416Arg cherubism mutation in sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties. Bone 2010; 46: 1306-1315.
 
14.
Mukherjee PM, Wang CJ, Chen IP, Jafarov T, Olsen BR, Ueki Y, Reichenberger EJ. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation and function. Am J Orthod Dentofacial Orthop 2010; 138: 140.e1-141.
 
15.
Carvalho VM, Perdigão PF, Amaral FR, de Souza PEA, De Marco L, Gomez RS. Novel mutations in the SH3BP2 gene associated with sporadic central giant lesions and cherubism. Oral Dis 2009; 15: 106-110.
 
16.
Meng XM, Yu SF, Yu GF. Clinicopathologic study of 24 cases of cherubism. Int J Oral Maxillofac Surg 2005; 34: 350-356.
 
17.
Bianchi SD, Boccardi A, Mela F, Romagnoli R. The computed thomographic apperience of cherubism. Skeletal Radiol 1987; 16: 6-10.
 
18.
Kaugars GE, Niamtu J. Cherubism: diagnosis, treatment, comparison with central giant cell granulomas and giant cell tumors. Oral Surg Oral Med Oral Pathol 1992; 73: 369-374.
 
19.
Chrcanovic BR, Guimarães LM, Gomes CC, Gomez RS. Cherubism: a systematic literature review of clinical and molecular aspects. Int J Oral Maxillofac Surg 2021; 50: 43-53.
 
20.
Cailleaux PE, Porporatti AL, Cohen-Solal M, Kadlub N, Coudert AE. Pharmacological management of cherubism: a systematic review. Front Endocrinol 2023; 14: https://doi.org/10.3389/fendo.....
 
21.
Liles SI, Hoppe IC, Arnold L. Denosumab therapy in cherubism. Cleft Palate Craniofac J 2023; 60: 1665-1673.
 
22.
Droma EB, Beck-Rosen G, Ilgiyaev A, Fruchtman Y, Abramovitch-Dahan C, Levaot N, Givol N. Positive outcomes of denosumab treatment in 2 patients with cherubism. J Oral Maxillofac Surg 2020; 78: 2226-2234.
 
23.
Jain V, Gamanagatti SR, Kataria P, Bhatti SS. Non-familial cherubism. Singapore Med J 2007; 48: e253-7.
 
24.
Silva EC, Silva GCC. Cherubism: clinicoradiographic featurs, treatment, long-term follow-up of 8 cases. J Oral Maxillofac Surg 2007; 65: 517-522.
 
25.
Silva EC, De Souza PEA, Barreto DC, Dias RP, Gomez RS. An extreme case of cherubism. Br J Oral Maxillofac Surg 2002: 40: 45-48.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top